New therapies for retinal vascular diseases on the way
Synthetic biology specialist Asimov has collaborated with biopharmaceutical company RevOpsis Therapeutics to develop therapies for retinal vascular diseases. Asimov’s CHO Edge System will be integrated into Rev Opsis’ RO-104. The CHO Edge System …